Prosecution Insights
Last updated: April 24, 2026
Application No. 18/248,492

Untitled Application

Unknown
Filed
1600
Examiner
PUTTLITZ, KARL J
Art Unit
1646
Tech Center
MEMORIAL SLOAN KETTERING CANCER CENTER
Assignee
Memorial Sloan Kettering Cancer Center
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
2y 8m
To Grant
87%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
974 granted / 1409 resolved
+9.1% vs TC avg
Strong +18% interview lift
Without
With
+18.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
58 currently pending
Career history
1467
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
37.6%
-2.4% vs TC avg
§102
11.3%
-28.7% vs TC avg
§112
26.8%
-13.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1409 resolved cases

Prosecution Timeline

1600
Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595284
AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
2y 5m to grant Granted Apr 07, 2026
Patent 12594343
TREATMENT OF CANCER
2y 5m to grant Granted Apr 07, 2026
Patent 12595307
Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors
2y 5m to grant Granted Apr 07, 2026
Patent 12577325
BISPECIFIC ANTIBODY-CAMPTOTHECIN DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF
2y 5m to grant Granted Mar 17, 2026
Patent 12568960
ADJUVANT COMBINATIONS AS FOLIAR UPTAKE ACCELERATOR FOR HERBICIDAL COMPOSITIONS
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
87%
With Interview (+18.2%)
2y 8m
Median Time to Grant
Low
PTA Risk
Based on 1409 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month